ACW successful FDA meeting on Alzheimers program
Released 14 Sep 25
Latest announcements
Announcement summary
ACW successful FDA meeting on Alzheimers program
Ask a question
Your question will be sent privately to Actinogen. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Actinogen a question about this announcement.